hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

AstraZeneca

Member of UN Global Compact

Headquarters in United Kingdom

AstraZeneca website

Response rate: 100%

(click here for an explanation)

🔎 Run a search for “AstraZeneca”

Get RSS feed of these results

All stories

Article
9 November 2004

AstraZeneca CEO Speaks About Value of Medicines to Patients and Society Being at The Core of The Company's Commitment to Corporate Responsibility

Author: AstraZeneca

Sir Tom McKillop, Chief Executive Officer, AstraZeneca...said, "...it is my profound belief that our most important contribution to society is the innovation we bring to improving global healthcare."

Read more

Article
9 December 2004

Pharmaceutical corporate giving benefits Puerto Rico [USA]

Author: Marialba Martinez, Caribbean Business [Puerto Rico]

...pharmaceutical manufacturing companies in Puerto Rico are spending millions of dollars annually to improve the well-being of their current and potential clients...KLD Research & Analytics recently rated 3,000 companies on how good they were as...

Read more

Article
20 December 2004

Pharmaceutical company CEO comments on corporate responsibility

Author: Pharma Business Week

...Tom McKillop, CEO, AstraZeneca, said, "...[in the case of] medicines for AIDS or TB...partnerships involving governments, international aid agencies and companies offer the best chance of advancing healthcare in the poorest parts of the world."

Read more

Article
30 December 2004
+ Español - Hide

Author: Expansion.com

Numerosas empresas europeas se han volcado con los damnificados por el debastador terremoto que ha asolado el sureste asiático cobrandose la vida de más de 120.000 personas y han anunciado millionarias donanciones para los países afectados. [se refiere...

Read more

Article
31 December 2004

[PDF] Business and Economic Development: Pharmaceutical Sector Report

Author: AccountAbility & Business for Social Responsibility

[refers to Merck, Novo Nordisk, Aspen Pharmacare, Grunenthal, Novartis, Citadel Aurobindo Biotech & Citadel Fine Pharmaceuticals (both part of Aurobindo Pharmaceuticals), Abbott Laboratories, Bristol Myers-Squibb, Pfizer, Schering-Plough, Eli...

Read more

Story
1 March 2005

GlaxoSmithKline, AstraZeneca, Merck, Pfizer & other firms join UK govt. in committing to increased access to essential medicines for poorest countries, including via differential pricing

See full story

Article
1 March 2005

[PDF] Increasing people’s access to essential medicines in developing countries: a framework for good practice in the pharmaceutical industry

Author: UK Department for International Development (DFID)

Responsibility for increasing access to essential medicines rests with the whole international community...In this context there is a particular role for pharmaceutical companies. As the producers of existing, and developers of new, medicines they can...

Read more

Article
30 March 2005

Renewed Commitment to Government – Industry Partnership to Improve Access to Medicines

Author: UK Department for International Development (DFID)

The UK Government and the world’s largest pharmaceutical companies today committed to continue to work together to help increase access to essential medicines for the world’s poorest countries...The UK Government’s framework for good practice has been...

Read more

Article
27 April 2005

[PDF] Neglected diseases gets shot in arm

Author: Andrew Jack, Financial Times

While neglected diseases such as malaria and tuberculosis infect millions of people every year and kill hundreds of thousands, their concentration in low-income countries that have little ability to pay means the drugs industry has long turned its...

Read more

Story
1 May 2005

Steps companies can take to manage impact of HIV/AIDS in Brazil, Russia, India, China

See full story